Sysmex nabs FDA clearance for addition to analyzer

2022 06 15 18 37 7431 Xn 1000 Bb Thumbnail

Sysmex America said Wednesday it has received FDA clearance for the addition of residual white blood cell counting to its XN-10 Automated Hematology Analyzer with Blood Bank mode.

The analyzer also supports red blood cell and platelet component testing in a single sample aspiration, providing blood processing centers with increased efficiency, consistency, and accuracy, the firm said.

The XN-10 with Blood Bank mode features analysis of blood components with four different selectable profiles: two profiles for red blood cell concentrates and two profiles for platelet concentrates.

Image courtesy of Sysmex America.Image courtesy of Sysmex America.

The scalable hematology system is available as a single module or twin coprimary analyzers and may be installed as a tabletop analyzer or placed on a wagon. Either model may be made more efficient with the addition of its RU-20 reagent unit, Sysmex said.

Page 1 of 7
Next Page